BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7884173)

  • 1. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group.
    Irvine EJ
    J Clin Gastroenterol; 1995 Jan; 20(1):27-32. PubMed ID: 7884173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of magnetic resonance imaging in evaluation of the activity of perianal Crohn's disease.
    Villa C; Pompili G; Franceschelli G; Munari A; Radaelli G; Maconi G; Cornalba GP
    Eur J Radiol; 2012 Apr; 81(4):616-22. PubMed ID: 21316171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
    Thia KT; Sandborn WJ; Lewis JD; Loftus EV; Feagan BG; Steinhart AH; Hanauer SB; Persson T; Sands BE
    Am J Gastroenterol; 2008 Dec; 103(12):3123-31. PubMed ID: 18786111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
    Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J
    Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.
    Tarrant KM; Barclay ML; Frampton CM; Gearry RB
    Am J Gastroenterol; 2008 Dec; 103(12):3082-93. PubMed ID: 19086959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
    Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
    Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of perianal Crohn's disease.
    Ingle SB; Loftus EV
    Dig Liver Dis; 2007 Oct; 39(10):963-9. PubMed ID: 17720635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perianal Crohn's disease.
    Khaikin M; Chowers Y; Zmora O
    Isr Med Assoc J; 2007 Mar; 9(3):163-8. PubMed ID: 17402327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of perianal Crohn's disease.
    Ardizzone S; Maconi G; Cassinotti A; Massari A; Porro GB
    Dig Liver Dis; 2007 Oct; 39(10):970-8. PubMed ID: 17720640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term quality of life in patients with Crohn's disease and perianal fistulas: influence of fecal diversion.
    Kasparek MS; Glatzle J; Temeltcheva T; Mueller MH; Koenigsrainer A; Kreis ME
    Dis Colon Rectum; 2007 Dec; 50(12):2067-74. PubMed ID: 17680311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.
    Jones J; Loftus EV; Panaccione R; Chen LS; Peterson S; McConnell J; Baudhuin L; Hanson K; Feagan BG; Harmsen SW; Zinsmeister AR; Helou E; Sandborn WJ
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1218-24. PubMed ID: 18799360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of topical metronidazole (10 percent) in the treatment of anorectal Crohn's disease.
    Stringer EE; Nicholson TJ; Armstrong D
    Dis Colon Rectum; 2005 May; 48(5):970-4. PubMed ID: 15785894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease.
    Cat H; Sophani I; Lemann M; Modiglani R; Solue JC
    Turk J Gastroenterol; 2003 Jun; 14(2):121-7. PubMed ID: 14614639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with infliximab therapy in 100 patients with Crohn's disease.
    Farrell RJ; Shah SA; Lodhavia PJ; Alsahli M; Falchuk KR; Michetti P; Peppercorn MA
    Am J Gastroenterol; 2000 Dec; 95(12):3490-7. PubMed ID: 11151882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perianal Crohn's disease and pregnancy: role of the mode of delivery.
    Ilnyckyji A; Blanchard JF; Rawsthorne P; Bernstein CN
    Am J Gastroenterol; 1999 Nov; 94(11):3274-8. PubMed ID: 10566729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical therapy of perianal Crohn's disease.
    Singh B; George BD; Mortensen NJ
    Dig Liver Dis; 2007 Oct; 39(10):988-92. PubMed ID: 17723322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.